Found 8 matching trials
Multiple Oral Doses of BI 207127 NA in Treatment naïve and Treatment-experienced Hepatitis C Virus (HCV)-Infected Patients PHASE1 The purpose of this study was to investigate antiviral activity, safety and...
Show More Location
Multiple Locations
Learn More & Join Trial
IFN-free Combination Therapy in HCV-infected Patients Treatment-naive:HCVerso1 PHASE3 The aim of the study is to confirm efficacy of treatment for 16 and 24 week...
Show More Location
1241.20.00026 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Thorough QT Study to Evaluate the Effects of BI 207127 (Deleobuvir) Combined With Faldaprevir on Cardiac Safety Parameters in Healthy Subjects. PHASE1 The objective of this study is to evaluate the effect of multiple doses of ...
Show More Location
1241.40.1 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Phase 3 Study of BI 207127 in Combination With Faldaprevir and Ribavirin for Treatment of Patients With Hepatitis C Infection, Including Patients Who Are Not Eligible to Receive Peginterferon: HCVerso2 PHASE3 The aim of the study is to confirm efficacy and safety of treatment with 60...
Show More Location
1241.36.00016 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Single Rising Oral Doses of BI 207127 NA as Powder in the Bottle in Healthy Male Subjects PHASE1 The objective of this trial was to investigate the safety, tolerability, ph...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of PPI-668, BI 207127 and Faldaprevir, With and Without Ribavirin, in the Treatment of Chronic Hepatitis C PHASE2 This study is designed to provide a preliminary assessment of the safety an...
Show More Location
Quest Clinical Research
Learn More & Join Trial
Single Rising Dose Study of BI 207127 NA in Healthy Male Asian Volunteers and Single Dose Study of BI 207127 NA in Healthy Male Caucasian Volunteers PHASE1 The aim of the study is to evaluate safety, tolerability and pharmacokineti...
Show More Location
1241.8.8201 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
4 Week Combination of BI 207127 NA With Peg-IFN and Ribavirin in Chronic HCV Patients PHASE1 The main purpose of this clinical trial with BI 207127 is to see the effect...
Show More Location
1241.7.3307A CHU de Grenoble
Learn More & Join Trial